Reduced miR-215 expression predicts poor prognosis in patients with acute myeloid leukemia

Japanese Journal of Clinical Oncology
Yu-Xin WangJun Qian

Abstract

Abnormal expression of microRNA-215 has been identified in a variety of solid cancers. However, little is known about the expression pattern of microRNA-215 in acute myeloid leukemia. This study was to investigate the status of microRNA-215 expression and further analyze its clinical significance in acute myeloid leukemia. Real-time quantitative polymerase chain reaction assay was performed to evaluate the expression level of microRNA-215 in 113 patients with acute myeloid leukemia. Besides, the relationship between microRNA-215 levels and clinical and pathological factors was explored. Compared with the healthy individuals, microRNA-215 expression in acute myeloid leukemia patients was significantly down-regulated (P= 0.001). MicroRNA-215 low-expressed patients had higher white blood cells than microRNA-215 high-expressed patients (P= 0.014). The incidence of FLT3/ITD mutation in the patients with low microRNA-215 expression was significantly higher than those with high microRNA-215 expression (P= 0.025). MicroRNA-215 low-expressed patients had significantly shorter overall survival than microRNA-215 high-expressed patients in both non-M3 acute myeloid leukemia patients and cytogenetically normal patients (P= 0.017 and P= 0.04...Continue Reading

References

Sep 20, 2002·Blood·James W VardimanRichard D Brunning
Feb 4, 2003·Nature Reviews. Cancer·Daniel G Tenen
Mar 23, 2004·Mini Reviews in Medicinal Chemistry·Michael C Heinrich
Mar 5, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Liang-In LinHwei-Fang Tien
Jun 10, 2005·Nature·Jun LuTodd R Golub
Oct 25, 2006·Nature Reviews. Cancer·George A Calin, Carlo M Croce
Dec 14, 2006·International Journal of Cancer. Journal International Du Cancer·Wei WuJianjun Chen
May 3, 2008·The New England Journal of Medicine·Guido MarcucciClara D Bloomfield
Sep 10, 2008·Blood·Janet D Rowley
Dec 17, 2008·Cancer Research·Christian J BraunMatthias Dobbelstein
Jan 24, 2009·Journal of Genetics and Genomics = Yi Chuan Xue Bao·Rui Zhang, Bing Su
Dec 24, 2009·Nature Reviews. Cancer·Jianjun ChenJanet D Rowley
Mar 20, 2010·The British Journal of Surgery·B P L WijnhovenUNKNOWN South Australian Oesophageal Research Group
Mar 16, 2011·Diagnostic Pathology·Johanna M KralikGerald Webersinke
Jul 15, 2011·Clinical Colorectal Cancer·Mihriban KaraayvazJingfang Ju
Apr 4, 2012·Journal of Cellular and Molecular Medicine·Petra FaltejskovaOndrej Slaby
Mar 26, 2013·American Journal of Hematology·Elihu H Estey
Aug 29, 2013·Cancer Letters·Yujie DengTianhua Zhou
Nov 28, 2013·Japanese Journal of Clinical Oncology·Qi XueGuo-Xin Li
Apr 9, 2014·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Hua LiangFu-Jin Shen
Jul 24, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Quan LiWeiming Li
Mar 17, 2015·Proceedings of the National Academy of Sciences of the United States of America·Matthew F JonesAshish Lal
Apr 30, 2015·Japanese Journal of Clinical Oncology·Xianglun SunJie Zhang

❮ Previous
Next ❯

Citations

Sep 9, 2017·Journal of Cellular Physiology·Ting-Juan ZhangJun Qian
Feb 15, 2018·Cancer Biomarkers : Section a of Disease Markers·Jinhua YanPing Li
Sep 15, 2017·Oncotarget·Yue ZhangYue-Hua Jiang
Jun 20, 2018·Molecular Medicine Reports·Shumei WangXiaoling Ji
Dec 6, 2018·Journal of Cellular Physiology·Rajab MardaniHossein Pourghadamyari

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.